CIAM
MRNA icon

Caitong International Asset Management’s Moderna MRNA Stock Holding History

Caitong International Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-55,071
Closed -$2.8M – 3294
2026
Q1 		$2.8M Buy
+55,071
New +$2.57M 0.52% 40
2025
Q4 		– Sell
-1,766
Closed -$45.6K – 2223
2025
Q3 		$45.6K Sell
1,766
-9,174
-84% -$256K 0.03% 352
2025
Q2 		$302K Buy
10,940
+4,250
+64% +$112K 0.22% 52
2025
Q1 		$190K Buy
6,690
+4,567
+215% +$162K 0.14% 134
2024
Q4 		$88.3K Buy
+2,123
New +$101K 0.09% 276

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Caitong International Asset Management's MRNA Position: Q2 2026 in Review

Caitong International Asset Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 55,071 shares — an estimated $2.8M sold.

Caitong International Asset Management first reported a position in MRNA in Q4 2024 and held it in 5 quarters. The position peaked at $2.8M in Q1 2026. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Caitong International Asset Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 55,071 Moderna shares in Q2 2026, an estimated $2.8M.
  • Caitong International Asset Management first reported a position in Moderna in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Moderna position peaked at $2.8M in Q1 2026.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.